よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


資料5 新谷参考人提出資料 (13 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_44078.html
出典情報 厚生科学審議会 がん登録部会(第29回 10/7)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

第7次事業のデータからの副論文発表
1.

2.

3.
4.
5.
6.
7.
8.
9.
10.

11.

12.
13.

14.

Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung
Cancer Registry Database in 2010. Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese
Joint Committee of Lung Cancer Registry.J Thorac Oncol. 2019 Feb;14(2):212-222.
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung
Cancer Registry Study. Fukumoto K, Mori S, Shintani Y, Okami J, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Miyaoka E,
Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Lung Cancer. 2020 Nov;149:120-129.
Clinical features and outcomes of patients with stage I multiple primary lung cancers. Shintani Y, Okami J, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Date H, Endo S,
Nagayasu T, Nakanishi R, Miyaoka E, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Cancer Sci. 2021 May;112(5):1924-1935.
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases. Suda K, Mitsudomi T, Shintani Y, Okami J, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI,
Asamura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Miyaoka E, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Ann Thorac Surg. 2021 Jan;111(1):269-276.
Preoperative renal dysfunction and long-term survival after surgery for non-small cell lung cancer. Saito T, Murakawa T, Shintani Y, Okami J, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee
of Lung Cancer Registry. J Thorac Cardiovasc Surg. 2022 Jul;164(1):227-239.
Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study. Soh J, Toyooka S, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Asamura H,
Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Eur J Cardiothorac Surg. 2022 Jun 15;62(1):ezac342.
Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010. Yamauchi Y, Kawamura M, Okami J, Shintani Y,
Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Endo S, Kadokura M, Nakanishi R, Miyaoka E, Suzuki H, Yoshino I, Date H. Cancers (Basel). 2022 Oct 19;14(20):5119.
The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010. Ito H,
Date H, Shintani Y, Miyaoka E, Nakanishi R, Kadokura M, Endo S, Chida M, Yoshino I, Suzuki H; Japanese Joint Committee of Lung Cancer Registry. BMC Cancer. 2022 Aug 10;22(1):875.
Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database. Matsuura Y, Mun M, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T,
Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. J Surg Oncol. 2023 Oct;128(5):916-924.
Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data
from Japan. Adachi H, Saito A, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H, Japanese Joint
Committee Of Lung Cancer Registry. Jpn J Clin Oncol. 2023 Dec 7;53(12):1191-1200.
Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non-Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide
Real-World Data. Adachi H, Morohoshi T, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese
Joint Committee of Lung Cancer Registry. Clin Lung Cancer. 2024 Jan;25(1):61-71.
Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data. Hishida T, Okami J, Asamura H, Miyaoka E,
Shintani Y, Kadokura M, Endo S, Chida M, Suzuki H, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Clin Lung Cancer. 2024 May 27:S1525-7304(24)00107-4.
Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in Japan. Tane S, Okami J, Maniwa Y, Shintani Y, Ito H, Ohtsuka T,
Toyooka S, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Surg Today. 2024 Apr 18.
doi: 10.1007/s00595-024-02844-8.
Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010. Kaseda K, Asakura K, Shintani Y, Okami J, Toyooka S, Sato Y, Watanabe SI, Chida M, Suzuki H,
Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. BMC Cancer. 2024 Aug 2;24(1):938. doi: 10.1186/s12885-024-12728-2.